Search results for "parathyroid"

showing 10 items of 164 documents

Is secondary hyperparathyroidism-related myelofibrosis a negative prognostic factor for kidney transplant outcome?

2011

Secondary hyperparathyroidism (HP) presenting with hypocalcemia and subsequent increased parathormone (PTH), is mainly identified in patients with chronic renal failure, which has been associated with variable degrees of bone marrow fibrosis. For suitable patients with end-stage renal disease (ESRD), kidney transplantation is recognized as the therapy of choice, being superior to dialysis in terms of quality of life and long-term mortality risk; in this regard interesting data show that increased time on dialysis prior to kidney transplantation is associated with decreased graft and patient survival. In our opinion an important and until now underestimated determinant of graft survival is t…

Nephrologymedicine.medical_specialtymedicine.medical_treatmentUrologySettore BIO/13 - Biologia ApplicataInternal medicinemedicineHumansMyelofibrosisKidney transplantationDialysisSettore MED/14 - NefrologiaHyperparathyroidismbusiness.industryGeneral MedicinePrognosismedicine.diseaseKidney TransplantationSurgerySettore MED/18 - Chirurgia Generalemedicine.anatomical_structurePrimary MyelofibrosisKidney Failure ChronicSecondary hyperparathyroidism myelofibrosis kidney transplant chronic renal desease hemopoietic stem cells ischemia/reperfusion damegeHyperparathyroidism SecondarySecondary hyperparathyroidismBone marrowStem cellbusinessMedical Hypotheses
researchProduct

Clinical Approach to Vascular Calcification in Patients With Non-dialysis Dependent Chronic Kidney Disease: Mineral-Bone Disorder-Related Aspects

2021

Chronic kidney disease (CKD) is associated with a very high morbimortality, mainly from cardiovascular origin, and CKD is currently considered in the high- or very high risk- cardiovascular risk category. CKD-mineral and bone disorders (CKD-MBDs), including vascular and/or valvular calcifications, are also associated with these poor outcomes. Vascular calcification (VC) is very prevalent (both intimal and medial), even in non-dialysis dependent patients, with a greater severity and more rapid progression. Simple X-ray based-scores such as Adragão's (AS) are useful prognostic tools and AS (even AS based on hand-X-ray only) may be superior to the classic Kauppila's score when evaluating non-d…

OncologyMedicine (General)medicine.medical_specialtyMini Review030232 urology & nephrologyParathyroid hormonePhosphate030204 cardiovascular system & hematologyCalcificationcalcification03 medical and health sciencesR5-9200302 clinical medicineInternal medicineVitamin D and neurologymedicineCKDCKD-MBDVascular calcificationphosphateVascular calcificationCalciprotein particlesSurrogate endpointbusiness.industryIncidence (epidemiology)General Medicinemedicine.diseasePathophysiologyvascular calcificationInsuficiència renal crònicaMedicinecalciprotein particlesbusinessCalcificationKidney diseaseFrontiers in Medicine
researchProduct

565 Reflection on a Case of Dopamine-Responsive Dystonia

2012

Background Characteristic symptoms of Dopamine-responsive dystonia (DRD) are increased muscle tone and Parkinsonian features. Children with DRD are often misdiagnosed. The disorder responds well to treatment with Levodopa. Aim To reflect on a case of DRD. Method Case report of a 13 years old girl misdiagnosed with tetany. Results The girl was hospitalized for opisthotonus, positive Trousseau and Chvostek signs, diagnosed as tetany. The laboratory analysis have shown: normal serum of calcium (2.28 mmol/l), normal serum of magnesium (0.80 mmol/l), normal serum of phosphor (1.26 mmol/l), normal alkaline phosphatase (261 u/l) and normal PTH (27.9 pg/ml). Although the initial evolution was favor…

OpisthotonusDystoniamedicine.medical_specialtyLevodopabusiness.industryTetanymedicine.diseaseGastroenterologyMuscle toneEndocrinologymedicine.anatomical_structureHypoparathyroidismInternal medicinePediatrics Perinatology and Child HealthMedicineFamily historymedicine.symptombusinessChvostek signmedicine.drugArchives of Disease in Childhood
researchProduct

Serum 25-hydroxyvitamin D levels in patients with cutaneous lupus erythematosus in a Mediterranean region

2010

Low vitamin D levels have been found in patients with autoimmune diseases, including type I diabetes, rheumatoid arthritis, multiple sclerosis and systemic lupus erythematosus. The main source of vitamin D is exposure to sunlight, but the same solar radiation is known to exacerbate lupus erythematosus. We investigated the prevalence of vitamin D insufficiency in patients with cutaneous lupus erythematosus (CLE). We designed a cross-sectional study including 55 patients with CLE to measure their serum 25-hydroxyvitamin D (25(OH)D) by chemiluminescence immunoassay and compare it with a control group consisting of 37 healthy sex and age-matched subjects recruited from the patients' relatives a…

PaperAdultMaleVitaminmedicine.medical_specialtySubacute Lupus ErythematosusParathyroid hormoneSystemic Lupus ErythematosusGastroenterologyvitamin D deficiencyYoung Adultchemistry.chemical_compoundRheumatologyInternal medicineLupus Erythematosus CutaneousPrevalencemedicineVitamin D and neurologyHumansVitamin DAgedAged 80 and overLupus erythematosusSystemic lupus erythematosusMediterranean Regionbusiness.industryfungiCase-control studyMiddle AgedVitamin D Deficiencymedicine.diseaseCross-Sectional StudiesEndocrinologychemistryParathyroid HormoneCase-Control StudiesRheumatoid arthritisLuminescent MeasurementsCutaneous LupusFemalebusinessLupus
researchProduct

[Informed consent in thyroid and parathyroid surgery].

2005

The Authors outline the law problems and the practice implications of thyroid and parathyroid surgery from the point of view of the informed consensus of the patient, and expose the criteria they usually adopt in their clinical practice for such procedures. This problem is particularly important because is exceptionally needed in emergency; therefore the preoperative information must be completed as possible, illustrating the risks of the procedure and the possible solutions alternative to surgery.

Parathyroid GlandsInformed ConsentThyroid GlandHumansInformed consent parathyroid glands thyroid surgeryAnnali italiani di chirurgia
researchProduct

Parathyroid hormone-related protein (PTHrP)-dependent modulation of gene expression signatures in cancer cells

2022

PTHrP is encoded by PTHLH gene which can generate by alternative promoter usage and splicing mechanisms at least three mature peptides of 139, 141 and 173 amino acids with distinct carboxy terminus. PTHrP may undergo proteolytic processing into smaller bioactive forms, comprising an amino terminus peptide, which is the mediator of the "classical" PTH-like effect, as well as midregion and carboxy terminus peptides that act as multifaceted critical regulator of proliferation, differentiation and apoptosis via the reprogramming of gene expression in normal and neoplastic cells. Moreover, a nuclear/nucleolar localization signal sequence is present in the [87-107] domain allowing PTHrP nuclear i…

Parathyroid HormoneNeoplasmsParathyroid Hormone-Related ProteinHumansApoptosisSettore BIO/06 - Anatomia Comparata E CitologiaPeptidesTranscriptomeGene signatures Bone tumor Breast tumor Gastrointestinal tumor Prostate tumor Lung cancer Leukemia/lymphoma
researchProduct

The neuropeptide Pth2 modulates social behavior and anxiety in zebrafish

2021

SummaryAnimal behavior is strongly context-dependent and behavioral performance is often modulated by internal state. In particular, different social contexts can alter anxiety levels and modulate social behavior. The vertebrate-specific neuropeptide parathyroid hormone 2 (pth2) is directly regulated by the presence or absence of conspecifics in zebrafish. As its cognate receptor, the parathyroid hormone 2 receptor (pth2r), is widely expressed across the brain, we tested fish lacking the functional Pth2 peptide in several anxiety-related and social paradigms. Rodents lacking PTH2 display increased anxiety-related behavior. Here we show that the propensity to react to sudden stimuli with an …

Parathyroid hormone 2 receptorEarly juvenilemedicineNeuropeptideAnxietyEscape responseBiologymedicine.symptomReceptorbiology.organism_classificationZebrafishNeuroscienceSocial preferences
researchProduct

Comparison between Rapid Intraoperative and Central Laboratory Parathormone Dosage in 12 Kidney Transplant Candidates

2016

Abstract Background The rapid intraoperative parathormone (PTH) and at central laboratory PTH dosage gives similar results. The central laboratory provides results in longer times and higher costs. Intraoperative measurement can reduce time and costs during parathyroidectomy. Methods Twelve patients undergoing parathyroidectomy for hyperparathyroidism renal transplant candidates were included. Diagnosis was made by laboratory tests (serum calcium, PTH) and imaging techniques (ultrasonography and scintigraphy). All patients presented PTH levels of >400 pg/mL (the limit value to be maintained in list for kidney transplantation) and resistant to medical therapy. For each patient, 2 blood sampl…

ParathyroidectomyAdultMalemedicine.medical_specialtyWaiting Listsmedicine.medical_treatmentOperative TimeParathyroid hormoneScintigraphyKidney transplantCentral laboratory03 medical and health sciences0302 clinical medicineMonitoring IntraoperativemedicineHumansKidney transplantationParathyroidectomyHyperparathyroidismTransplantationmedicine.diagnostic_testbusiness.industryMiddle Agedmedicine.diseaseKidney TransplantationSurgery; TransplantationSurgerySettore MED/18 - Chirurgia GeneraleParathyroid Hormone030220 oncology & carcinogenesisAnesthesiaKidney Failure Chronic030211 gastroenterology & hepatologySecondary hyperparathyroidismFemaleHyperparathyroidism SecondarySurgerybusiness
researchProduct

Use of monitoring intraoperative parathyroid hormone during parathyroidectomy in patients on waiting list for renal transplantation.

2007

This report describes the use of intraoperative parathyroid hormone (ioPTH) assay during parathyroidectomy for patients with secondary hyperparathyroidism on the waiting list for renal transplantation. The levels of ioPTH were determined among waiting list patients undergoing subtotal parathyroidectomy and tertiary hyperparathyroidism patients undergoing procedures. The levels of ioPTH were significantly reduced at 10 minutes by 59.7,3% among with secondary hyperparathyroidism and 68.9% among tertiary hyperparathyroidism. A 15 minutes it was 85% in secondary hyperparathyroidism and 89.7% in tertiary hyperparathyroidism. A decrement of 50% in basal values at 10 minutes and 85% decrement or m…

ParathyroidectomyAdultMalemedicine.medical_specialtyendocrine system diseasesWaiting Listsmedicine.medical_treatmentParathyroid hormoneTertiary hyperparathyroidismSubtotal ParathyroidectomyMonitoring IntraoperativemedicineHumansKidney transplantationAgedParathyroidectomyTransplantationbusiness.industryMiddle Agedmedicine.diseaseKidney TransplantationSurgeryTransplantationSettore MED/18 - Chirurgia Generalemedicine.anatomical_structureParathyroid HormoneSurgerySecondary hyperparathyroidismParathyroid glandFemaleHyperparathyroidism SecondarybusinessParathyroidectomy hyperparathyroidismTransplantation proceedings
researchProduct

A complex case of fatal calciphylaxis in a female patient with hyperparathyroidism secondary to end stage renal disease of graft and coexistence of h…

2012

Background: Calciphylaxis is a potentially fatal complication of persistent secondary hyperparathyroidism; its cause is still not clear. Unfortunately there is no close relation in severity of clinical picture, serological and pathological alteration. For this reason the prognosis is difficult to establish. Administration of sodium thiosulphate may reduce the precipitation of calcium crystals and improve the general clinical conditions before surgical parathyroidectomy, which seems the only therapeutic approach able to reduce the mortality risk in these patients. Methods and Results: A 60 year old female patient suffering from End Renal Stage Disease, on haemodialysis from 2001 due to the o…

ParathyroidectomyGraft Rejectionmedicine.medical_specialtymedicine.medical_treatmentCalciphylaxiSettore MED/08 - Anatomia PatologicaGeneral Biochemistry Genetics and Molecular BiologyEnd stage renal diseaseFatal OutcomeSecondary hyperparathyroidism; Calciphylaxis; Kidney transplant; ParathyroidectomymedicineHumansKidney transplantDialysisParathyroidectomySettore MED/14 - NefrologiaCalciphylaxisHyperparathyroidismbusiness.industryCalciphylaxisMiddle Agedmedicine.diseaseKidney TransplantationSurgeryTransplantationSecondary hyperparathyroidismSettore MED/18 - Chirurgia GeneraleHemolytic-Uremic SyndromeKidney Failure ChronicSecondary hyperparathyroidismFemaleHyperparathyroidism SecondaryComplicationbusinessBiomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
researchProduct